NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE ... We sell different types of products and services to both investment ...

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. Formerly known as GlaxoSmithKline, ...

GSK has struck a $2.2 billion agreement to settle ... We sell different types of products and services to both investment professionals and individual investors. These products and services ...

GSK GSK stock has declined 20.2% in the past ... In the segment, while products like Nucala and Dovato are key top-line drivers, new long-acting HIV medicines, Cabenuva and Apretude, as well ...